The effect of placental angiogenic and anti-angiogenic factors on pregnancy outcome in patients with early onset preeclampsia

Creative Commons License

Kara M., Yalvaç E. S., Onat T., Başer E., Caltekin M. D., Aydoğan Kırmızı D., ...More

JOURNAL OF THE TURKISH-GERMAN GYNECOLOGICAL ASSOCIATION, vol.22, no.3, pp.212-216, 2021 (ESCI) identifier identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 22 Issue: 3
  • Publication Date: 2021
  • Doi Number: 10.4274/jtgga.galenos.2021.2020.0173
  • Journal Name: JOURNAL OF THE TURKISH-GERMAN GYNECOLOGICAL ASSOCIATION
  • Journal Indexes: Emerging Sources Citation Index (ESCI), Scopus, Academic Search Premier, CINAHL, EMBASE, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.212-216
  • Keywords: Preeclampsia, soluble fms-like tyrosine kinase 1, soluble endoglin, placental growth factor, DIAGNOSIS, HYPERTENSION, MANAGEMENT
  • Yozgat Bozok University Affiliated: Yes

Abstract

Objective: The aim was to evaluate the possible effects of anti-angiogenic factors including soluble endoglin (sEng), placental growth factor (Pgf), and soluble fms-like tyrosine kinase 1 (sFlt-1) in both normotensive pregnant patients and preeclampsia (PE) patients.